Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Цистит у женщин

Список литературы

  1. Kunin C.M. Urinary Tract Infections: Detection, Prevention and Manage- ment. — 5th ed. — Baltimore: Williams & Wilkins, 1997.
  2. Hooton T.M. Uncomplicated urinary tract infections. New England Journal of Medicine.2012; 366:1028-37;
  3. Перепанова Т.С. Неосложненная инфекция мочевых путей. В кн: «Рациональная фармакотерапия в урологии: Руководство для практикующих врачей-2 изд. исп, и доп/ под общ.ред. Н.А.Лопаткина, Т. С. Перепановой.-М.:Литтерра-2012.стр.303-318
  4. Nicolle LE. A Practical Guide to the Management of Complicated Urinary Tract Infection. Drugs. 1997;53:583-92.;
  5. Sofia Ny, Petra Edquist, Uga Dumpis, Kirsi Gr¨ondahl-Yli- Hannuksela, Julia Hermes, Anna-Maria Kling, Anja Klingeberg, Roman Kozlov, Owe K¨allman, Danuta O.Lis, Monika Pomorska-Wesołowska, M¯ara Saule, Karin Tegmark Wisell, Jaana Vuopio, Ivan Palagin, Antibiotic resistance of Escherichia coli from outpatient urinary tract infection in women in six European countries including Russia (2018), https://doi.org/10.1016/j.jgar.2018.11.004
  6. Shang YJ, Wang QQ, Zhang JR, Xu YL, Zhang WW, Chen Y, Gu ML, Hu ZD, Deng AM: Systematic review and meta-analysis of flow cytometry in urinary tract infection screening. Clin Chim Acta 2013; 424: 90–95
  7. Ana L. Flores-Mireles, Jennifer N. Walker, Michael Caparon, and Scott J. Hultgren. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May ; 13(5): 269–284. doi:10.1038/nrmicro3432
  8. Takashi Hato and Pierre C. Dagher. How the Innate Immune System Senses Trouble and Causes Trouble. Clin J Am Soc Nephrol. 2015 Aug 7; 10(8): 1459–1469. Published online 2014 Nov 20. doi: 10.2215/CJN.04680514
  9. Gerard Apodaca. The Uroepithelium: Not Just a Passive Barrier. Traffic 2004; 5: 117–128. doi: 10.1046/j.1600-0854.2003.00156.x 108: 415.
  10. Wagenlehner, F.M., et al. Uncomplicated urinary tract infections. Dtsch Arztebl Int, 2011.
    108: 415. https://www.ncbi.nlm.nih.gov/pubmed/21776311
  11. Stamm, W.E., et al. Management of urinary tract infections in adults. N Engl J Med, 1993. 329: 1328. https://www.ncbi.nlm.nih.gov/pubmed/8413414
  12. Foxman, B., et al. Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol, 2001. 54: 710. https://www.ncbi.nlm.nih.gov/pubmed/11438412
  13. Bent, S., et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA, 2002. 287: 2701. https://www.ncbi.nlm.nih.gov/pubmed/12020306
  14. Foxman, B., et al. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am, 2003. 17: 227.
  15. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745–758.
  16. Alidjanov JF, Abdufattaev UA, Makhsudov SA, Pilatz A, Akilov FA, Naber KG, Wagenlehner FM: New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urol Int 2014; 92: 230–236. Urol Int 2016; 96: 369.
  17. Alidjanov JF, Abdufattaev UA, Makhsudov SA, Pilatz A, Akilov FA, Naber KG, Wagenlehner FM: The acute cystitis symptom score for patient-reported outcome assessment. Urol Int 2016; 97: 402–409.
  18. K. G. Naber, Ж. Ф. Алиджанов. Существуют ли альтернативные методы антибактериальной терапии и профилактики неосложненных инфекций мочевыводящих путей? Урология, 2014, №6,с.5-13
  19. Chapple CR. Is a voiding diary really necessary in 2014? Eur Urol. 2014 Aug;66 (2):301-2. doi: 10.1016/j.eururo.2014.05.001. Epub 2014 May 15.;
  20. Bright E, Drake MJ, Abrams P. Urinary diaries: evidence for the development and validation of diary content, format, and duration. Neurourol Urodyn. 2011 Mar;30(3):348-52. doi: 10.1002/nau.20994. Epub 2011 Jan 31. Review.]
  21. Урология: национальное руководство/ под ред. Н. А. Лопаткина. -М.: ГЭОТАР- Медиа, 2009.- с. 484-490 –(Серия «Национальные руководства») ISBN 978-5-9704-0983-1
  22. Nicolle L.E. Asymptomatic bacteriuria – to treat or not to treat. In: Naber K.G., Schaeffer A.J., Heyns C., Matsumoto T., Shoskes D., Bjerklund-Johansen T.E., eds. Urogenital infections. Arnhem, Netherlands: European Association of Urology–International Consultation on Urological Diseases, 2010: 303–313
  23. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. «Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов» Федеральные клинические рекомендации 2017г,70с.
  24. Colgan R, Williams M.Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011 Oct 1;84(7):771-6. Review;
  25. Guglietta A. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol. 2017 Mar;12:239-246.
  26. McLellan LK, Hunstad DA. Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med.2016 Nov;22(11):946-957.
  27. G.Bonkat, R.R.Bartoletti, F.Bruyere, T.Cai, S.E.Geerlings, B.Koves, S. Schubert, F.Wagenlehner. EAU Guidelines on Urological Infections European Association of Urology 2019, 52 p. .
  28. Kaltenis P, Baciulis V, Liubsis A. Reliability of detection of leucocyturia by means of the dip-stick Cytur-Test. Int Urol Nephrol. 1984;16 (3):233-5.
  29. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014; 28:1–13.
  30. Hooton TM, Roberts PL, Cox ME, Stapleton AE Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med. 2013 Nov 14;369(20):1883-91. doi: 10.1056/NEJMoa1302186;
  31. Lindsay E. Nicolle, Kalpana Gupta, Suzanne F. Bradley, Richard Colgan, Gregory P. DeMuri, Dimitri Drekonja, Linda O. Eckert, Suzanne E. Geerlings, Béla Köves, Thomas M. Hooton, Manisha Juthani-Mehta, Shandra L. Knight, Sanjay Saint, Anthony J. Schaeffer, Barbara Trautner, Bjorn Wullt, Reed Siemieniuk. IDSA 2019 Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria • Clinical Infectious Diseases 2019: 3/21/2019. https://doi.org/10.1093/cid/ciy1121)
  32. Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K, Schmiemann G, Wagenlehner FM: The 2017 update of the German clinical guideline on epidemiology, diagnostics, therapy, prevention, and management of uncomplicated urinary tract infections in adult patients: Part I., Urol Int 2018
  33. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect, 2000. 6 (9):p.503-8
  34. Kass E.H. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 1960; 44:194–198.
  35. Wagenlehner F.M.E., Naber K.G. Asymptomatic bacteriuria – shift of paradigm. Clin Infect Dis 2012;55:778–779;
  36. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003; 49:53-70.
  37. Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018 Jul; 219 (1):40-51. doi: 10.1016/j.ajog.2017.12.231. Epub 2018 Jan 2.
  38. Silverman JA, Schreiber HL 4th, Hooton TM, Hultgren SJ. From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr Urol Rep. 2013; 14:448-56;
  39. Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health. 2012; 12:347-354.
  40. Wagenlehner FM, Vahlensieck W, Bauer HW, et al. Prevention of recurrent urinary tract infections. Minerva Urol. Nefrol. 2013; 65:9-20.
  41. Hopkins WJ, Elkahwaji J, Beierle LM, et al. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol. 2007; 12:1349-1353.
  42. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for the prevention of recurrent urinary tract infections. Can Journal Microbiol. 1988; 34:339-43.
  43. Geerlings SE, Beerepoot MA, Prins JM. Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies. Infect Dis Clin North Am. 2014 Mar;28(1):135-47. doi: 10.1016/j.idc.2013.10.001. Epub 2013 Dec 7.
  44. Cai T, Mazzoli S, Migno S, et al. Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection. Int J Urol. 2014; 21:929-34.
  45. В.В. Галкин, Е.В. Довгань, С.Н. Козлов, В.В. Рафальский. Цефиксим в сравнении с ципрофлоксацином при остром неосложненном цистите: клинико-экономическое исследование.Клин микробиол антимикроб химиотер 2012, Том 14, № 1, с.59-66
  46. Puech P, Lagard D, Leroy C, Dracon M, Biserte J, Lemaître L. Imaging in urinary tract infections in adults. J Radiol. 2004 Feb;85(2 Pt 2):220-40.
  47. Kim Y, Seo MR, Kim SJ, Kim J, Wie SH, Cho YK, Lim SK, Lee JS, Kwon KT, Lee H, Cheong HJ, Park DW, Ryu SY, Chung MH, Pai H. Usefulness of Blood Cultures and Radiologic Imaging Studies in the Management of Patients with Community-Acquired Acute Pyelonephritis. Infect Chemother. 2017 Mar;49(1):22-30. doi: 10.3947/ic.2017.49.1.22. Epub 2017 Feb 24.]
  48. Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, Fьnfstьck R, Helbig S, Hofmann W, Hummers E, Kunze M, Kniehl E, Naber K, Mandraka F, Mьndner- Hensen B, Schmiemann G, Wagenlehner FM: [Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients: update 2017 of the interdisciplinary AWMF S3 guideline]. Urologe 2017;56:746-758.;
  49. Ferry SA, Holm SE, Stenlund H, Monson TJ The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 2004; 36:296-301.;
  50. Christiaens TC, de Meyere M, Verschraegen G, Peersman W, Heytens S, de Maeseneer JM: Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52:729-734.
  51. Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G: Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol 2013; 190:1981-1989.
  52. Kurt G Naber , Yong-Hyun Cho, Tetsuro Matsumoto, Anthony J Schaeffer Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. International Journal of Antimicrobial Agents 2009; Feb; 33:111-19; doi: 10.1016/j.ijantimicag.2008.08.011.
  53. Aziminia N, Hadjipavlou M, Philippou Y, Pandian SS, Malde S, Hammadeh MY. Vaccines for the prevention of recurrent urinary tract infections: a systematic review. BJU Int. 2019 May;123(5):753-768. doi: 10.1111/bju.14606. Epub 2018 Dec 19. PMID: 30378242.
  54. Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K, Schmiemann G, Wagenlehner FM: The 2017 update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part II, Therapy and Prevention Urol Int 2018; 100:271-278 DOI: 10.1159/000487645
  55. Ivanov D, Abramov-Sommariva D, Moritz K, Eskötter H, Kostinenko T, Martynyuk L, Kolesnik N, Naber KG. An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs). Clinical Phytoscience. 2015;1:7. doi:10.1186/s40816-015-0008-x. ;
  56. Gessner A (2016): “The influence of urologic therapeutics on the microbiome in an experimental model” in “How the microbiome is influenced by the therapy of urological diseases: standard vs. alternative approaches”. 31st Annual EAU Congress, Munich 2016.
  57. Kurt G Naber. «Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia»// Research and Reports in Urology, Dovepress, 2013:5 39–46
  58. Dimitri Abramov-Sommariva, Martina Höller, Hubert Steindl,Kurt G. Naber. Non- Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, randomized, Multicentre, Non-Inferiority Phase III Trial Florian M. Wagenlehner. Internationalis Urologia DOI: 10.1159/000493368,Published online: September 19, 2018
  59. Dawson-Hahn EE, Mickan S, Onakpoya I, Roberts N, Kronman M, Butler CC, Thompson MJ. Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews. Fam Pract. 2017 Sep 01;34(5):511-519.
  60. Палагин И.С., Сухорукова М.В., Дехнич А.В., Эйдельштейн М.В., Перепанова Т.С., Козлов Р.С. и исследовательская группа «ДАРМИС-2018»* «Антибиотикорезистентность возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового исследования «ДАРМИС-2018» журнал Клиническая микробиология и антимикробная химиотерапия том 21,№2, с.134-146, 2019г. DOI: 10.36488/cmac.2019.2.134- 146
  61. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a crossnational database study. Lancet 2005;365(9459):579e87;
  62. Albert X, Huertas I, Pereiro II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004;(3):CD001209
  63. Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017 Mar;129 (2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21.
  64. Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202.
  65. Jennifer Anger, Una Lee, A. Lenore Ackerman, Roger Chou et al. American Urological Association (AUA)/Canadian Urological Association (CUA)/ Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) “Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline”/ Copyright © 2019 American Urological Association Education and Research, Inc.®, 36s.
  66. Gruneberg R.N. The use of nitrofurans in the treatment of urinary tract infections with some observations on the in vitro properties of nifuratel. In: F. Gasparri, G.Gargani, P.Periti, Firenze, Italy, 1972, pp.109-112;
  67. Mendling W, Mailland F. Microbiological and Pharmaco-toxicological Profile of Nifuratel and vits Favourable Risk/Benefit Ratio for the Treatment of Vulvo Vginal Infections/Arzneim Forsch/drug Res 2002;52(1):8-13;
  68. Jiří Kladenský, Věra Toršová, Eva Chmelařová PŘÍNOS NIFURATELU PRO LÉČBU AKUTNÍCH NEKOMPLIKOVANÝCH UROINFEKCÍ. Urolog. pro Praxi, 2006; 3: 108–110
  69. Albert. X, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev, 2004: CD001209, http:/www.ncbi.nlm.nih.gov/pubmed/15266443
  70. Osamwonyi B, Foley C, Management of recurrent urinary tract infections in adults, Surgery (2017), http:// dx.doi.org/10.1016/j.mpsur.2017.03.004
  71. Droupy S. The therapeutic approach to different forms of cystitis: impact on public health.Urologia. 2017 Sep 14;84(Suppl 1):8-15. doi: 10.5301/uj.5000262. Epub 2017 Aug 17.
  72. Costantini E, Lazzeri M, Pistolesi D, Del Zingaro M, Frumenzio E, Boni A, Pietropaolo A, Fragalà E, Porena M. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).Urol Int. 2013;91(1):81-8. doi: 10.1159/000345047. Epub 2013 Mar 13.
  73. Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review. Neurourol Urodyn. 2013 Jan;32(1):9-18. doi: 10.1002/nau.22256. Epub 2012 Jul 10.;
  74. Rocco Damiano The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease Ther Adv Urol. 2011 Oct; 3(5): 223–232. doi: [10.1177/1756287211418723
  75. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000;30:152e6.
  76. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;5:1072e9.
  77. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women (Review).Cochrane Database Syst Rev 2008;2:CD005131.
  78. M E Falagas, A C Kastoris, A M Kapaskelis, D E Karageorgopoulos. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010; 10: 43–50. www.thelancet.com/infection Vol 10 January 2010
  79. Tommaso Cai, Irene Tamanini, Carlo Tascini, Bela Köves, Gernot Bonkat, Mauro Gacci, Andrea Novelli, Juan Pablo Horcajada, Truls E. Bjerklund Johansen, George Zanel. Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis. J Urol. 2020 Mar;203(3):570- 578. https://doi.org/10.1097/JU.0000000000000620
  80. Patel SS, Balfour JA, Bryson HM.. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs. 1997 Apr;53(4):637-56. doi: 10.2165/00003495-199753040-00007.PMID: 9098664 Review
  81. Keating GM. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs. 2013 Nov;73(17):1951-66. doi: 10.1007/s40265-013-0143- y.PMID: 24202878 Review.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*